compound tirzepatide ban update 🚨There's been a lot of confusion lately, so let's clear this up… Compounded GLP-1 medications (like semaglutide and tirzepatide) are not banned entirely — but access is changing. The FDA has ended Compounded Tirzepatide 2 Month Program

Vitamin C deficiency can lead to scurvy, a condition characterized by fatigue, weakness, gum disease and skin abnormalities

Appetite 123 , 1422 (2018)

More than three-quarters of patients taking both drugs reported at least one side effect, mostly mild to moderate gastrointestinal issues such as nausea, constipation, diarrhea and vomiting

Blood sugar improvements Better glucose control can slow CKD progression, particularly for people with diabetic kidney disease

Is testing for postprandial hyperinsulinemic hypoglycemia after gastric bypass necessary

Diabetes 62:11311138 Cegla J, Troke RC, Jones B et al (2014) Coinfusion of low-dose GLP-1 and glucagon in man results in a reduction in food intake